Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Post-authorization Prospective Study to Characterize the Incidence of Epidermal Growth Factor Receptor (EGFR) Mutation Positive and Advanced Non-small Cell Lung Cancer Patients and Their Clinical Management in Galicia

NCT01717105 is registered in ClinicalTrials.gov with Grupo Gallego de Cancer de Pulmon as lead sponsor.

NCT NCT01717105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01717105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Post-authorization Prospective Study to Characterize the Incidence of Epidermal Growth Factor Receptor (EGFR) Mutation Positive and Advanced Non-small Cell Lung Cancer Patients and Their Clinical Management in Galicia
Lead sponsor
Grupo Gallego de Cancer de Pulmon
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2011
Completion date
February 28, 2013
Enrollment
225 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic non-small-cell lung cancer